4//SEC Filing
BAFFI ROBERT 4
Accession 0001567619-19-006231
CIK 0001048477other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:28 PM ET
Size
7.7 KB
Accession
0001567619-19-006231
Insider Transaction Report
Form 4
BAFFI ROBERT
SVP, Technial Operations
Transactions
- Award
Common Stock
2019-03-01+11,853→ 95,129 total - Tax Payment
Common Stock
2019-03-01$94.76/sh−917$86,895→ 94,212 total
Holdings
- 71,882(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.
- [F2]Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2018 as set forth in the Issuer's audited financial statements.
- [F3]Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 15, 2019, 2020 and 2021, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.
Documents
Issuer
BIOMARIN PHARMACEUTICAL INC
CIK 0001048477
Entity typeother
Related Parties
1- filerCIK 0001274826
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:28 PM ET
- Size
- 7.7 KB